Outsourced Pharma Capacity Update Videos - Large Molecule
-
OPCU October 2025: Large Molecule
10/16/2025
Advance your biotherapeutic with a trusted global CDMO partner offering end-to-end development and manufacturing, supported by state-of-the-art facilities and a commitment to your success.
-
Nanoform Capacity Update October 2025: Large Molecule
10/16/2025
Sergie Letser, Deputy CCO, presents an overview of Nanoform’s novel large molecule nanoforming technology capabilities and current capacity.
-
Cytovance Biologics Capacity Update October 2025: Large Molecule
10/16/2025
Partner with a U.S.-based, trusted CDMO large enough to support every stage of your program, yet agile enough to deliver the dedicated care your project deserves.
-
From Concept To Market: Mammalian Protein Development And Manufacturing
10/16/2025
With proven expertise in process development, optimization, and CGMP manufacturing, Avid offers end-to-end CDMO solutions backed by flexible capacity designed to scale with program needs.
-
AGC Biologics Capacity Update October 2025: Large Molecule
10/16/2025
Michael Brotz provides an in-depth look at our Seattle site and the unique capabilities of the facility, including its single-use and stainless-steel capacity, new manufacturing lines, and more.
-
Samsung Biologics Capacity Update October 2025: Large Molecule
10/16/2025
Accelerate your cancer therapy development with patient-derived organoids — high-fidelity models that enhance translational confidence, streamline discovery, and bring promising treatments to the clinic faster.
-
Novartis Contract Manufacturing Capacity Update October 2025: Large Molecule
10/16/2025
Gain insight into our global manufacturing network, including information about the capabilities of each mammalian and microbial site within the network.
-
Northway Biotech Capacity Update October 2025: Large Molecule
10/16/2025
André Markmann, VP of Business Development, shares insights drawn from over 20 years of experience, more than 185 successful projects, and fully integrated microbial and mammalian facilities in Waltham, Massachusetts, and Vilnius, Lithuania.
-
MilliporeSigma Capacity Update October 2025: Large Molecule
10/16/2025
Our global facilities are built to guide you when you’re ready to scale; and power your mRNA journey from discovery to global commercialization.
-
KBI Biopharma Capacity Update October 2025: Large Molecule
10/16/2025
Accelerate your biopharmaceutical program with a flexible, global manufacturing partner that minimizes risk, shortens timelines, and empowers seamless scaling from clinical to commercial production.